Biophore applies to DCGI for emergency-use approval for COVID treatment drug
Business | Jun 11, 2021, 11:36 AM ISTBiophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to severe cases of COVID-19.